Seroprevalence 36 Months after a Single-dose Bivalent Human Papillomavirus Vaccination among Nine to Fifteen-year-old Girls in Dhaka, Bangladesh: A Cross-sectional Study

Authors:

Abstract
Immunization against human papillomavirus (HPV), particularly with a single-dose vaccine, offers a cost-effective strategy for cervical cancer prevention. This study aimed to evaluate the seroprevalence following a single-dose bivalent HPV vaccine among adolescent girls in Bangladesh and to examine its association with sociodemographic characteristics.